Trial Profile
METformin With a Carbohydrate Restricted Diet in Combination With Platinum Based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer (NS-NSCLC) - METRO Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2015
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Carboplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms METRO
- 20 Apr 2015 Planned End Date changed from 1 Sep 2015 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
- 09 Oct 2014 New trial record